PNV TABS 20-1- beta carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, pyridoxine hydrochloride, biotin, folic acid, levomefolate calcium, cyanocobalamin, calcium carbonate, magnesium oxide, ferrous bisglycinate, and potassium iodide tablet 
Redmont Pharmaceuticals, LLC

----------

PNV Tabs 20-1

71741-091-30

Prenatal/Postnatal Dietary Supplement

Dispensed by Prescription

DESCRIPTION

PNV Tabs 20-1 is a prescription prenatal/postnatal multivitamin/multimineral dietary supplement.

Supplement Facts
Serving size 1 Tablet
Amount per Serving:%Daily Value
*
Daily Value not established
Vitamin A (as Beta-Carotene)300 mcg RAE33%
Vitamin C (as Ascorbic Acid)60 mg67%
Vitamin D (as Cholecalciferol)10 mcg50%
Vitamin E (as dl-Alpha Tocopherol Acetate)4.5 mg (10 IU)33%
Vitamin B6 (as Pyridoxine HCl)26 mg1529%
Biotin0.280 mg933%
Folate1.67 mg DFE418%
  (from Folic Acid)0.67 mg DFE*
  (from 5-Methyl Tetrahydrofolate, Calcium Salt)1 mg DFE*
Vitamin B12 (as Cyanocobalamin)0.013 mg542%
Calcium (as Calcium Carbonate)80 mg6%
Magnesium (as Magnesium Oxide)25 mg6%
Ferrochel™ Iron (as Ferrous BisGlycinate Chelate)20 mg111%
Iodine (as Potassium Iodide)0.150 mg100%

OTHER INGREDIENTS: Microcrystalline Cellulose, Maltodextrin, Croscarmellose Sodium, Silicon Dioxide, Stearic Acid, Magnesium Stearate, Film Coating (Hydroxypropyl Methylcellulose, Polyethylene Glycol, Titanium Dioxide, FD&C Blue # 1)

Allergen: NONE

INDICATIONS

PNV Tabs 20-1 is a multivitamin/multimineral dietary supplement indicated for the use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating or non-lactating mothers.

PNV Tabs 20-1 can also be beneficial in improving the nutritional status of women prior to conception.

CONTRAINDICATIONS

PNV Tabs 20-1 is contraindicated in patients with a known hypersensitivity to any of the ingredients.

PRECAUTIONS

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poising in children under 6. Keep this product out of the reach of children. In the case of accidental overdose, call a doctor or poison control center immediately.

ADVERSE REACTIONS

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact Redmont Pharmaceuticals, LLC at 1-800-986-5909.

DOSAGE AND ADMINISTRATION

Before, during and/or after pregnancy, one tablet daily or as directed by a physician.

HOW SUPPLIED

Bottles of 30 tablets (71741-091-301). Tablet is light blue, oblong.

This product is a prescription-folate with or without other dietary ingredients that – due to increased folate levels increased risk associated with masking B12 deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (64 FR 8760). 1-3 The most appropriate way to ensure pedigree reporting consistent with these regulatory guidelines and safety monitoring is to dispense this product only by prescription. This is not an Orange Book product. This product may be administered only under a physician's supervision and all prescriptions using this product shall be pursuant to state statues as applicable. The ingredients, indication or claims of this product are not to be construed to be drug claims.

  1. Federal Register Notice of August 2, 1973
    (38 FR 20750)
  2. Federal Register Notice of October 17, 1980
    (45 FR 69043, 69044)
  3. Federal Register Notice of March 5, 1996
    (61 FR 8760)

1
Redmont Pharmaceuticals does not represent this product code to be National Drug Code (NDC). Product codes are formatted according to standard industry practice, to meet the formatting requirement by pedigree reporting and supply-chain control including pharmacies.

STORAGE AND HANDLING

STORAGE

Store at 20°-25° C (68°-77°F) excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.] Avoid excessive heat, light and moisture.

TAMPER EVIDENT

Do not use if seal is broken or missing.

MADE IN USA

REDMONT
PHARMACEUTICALS

Distributed by:

Redmont Pharmaceuticals, LLC
Birmingham, AL 35209
800-986-5909

Ferrochel™ is a trademark of Albion Laboratories, Inc.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

© 2021 Redmont Pharmaceuticals, LLC
091111-0121

PRINCIPAL DISPLAY PANEL - 30 Tablet Bottle Label

71741-091-30

PNV Tabs 20-1

PRENATAL/POSTNATAL
Dietary Supplement

30 TABLETS

Dispensed by Prescription

PRINCIPAL DISPLAY PANEL - 30 Tablet Bottle Label
PNV TABS 20-1 
beta carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, pyridoxine hydrochloride, biotin, folic acid, levomefolate calcium, cyanocobalamin, calcium carbonate, magnesium oxide, ferrous bisglycinate, and potassium iodide tablet
Product Information
Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:71741-091
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Beta Carotene (UNII: 01YAE03M7J) (Beta Carotene - UNII:01YAE03M7J) Beta Carotene300 ug
Ascorbic Acid (UNII: PQ6CK8PD0R) (Ascorbic Acid - UNII:PQ6CK8PD0R) Ascorbic Acid60 mg
Cholecalciferol (UNII: 1C6V77QF41) (Cholecalciferol - UNII:1C6V77QF41) Cholecalciferol10 ug
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) (.ALPHA.-TOCOPHEROL - UNII:H4N855PNZ1) .ALPHA.-TOCOPHEROL ACETATE4.5 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE HYDROCHLORIDE26 mg
Biotin (UNII: 6SO6U10H04) (Biotin - UNII:6SO6U10H04) Biotin0.28 mg
Folic Acid (UNII: 935E97BOY8) (Folic Acid - UNII:935E97BOY8) Folic Acid0.4 mg
LEVOMEFOLATE CALCIUM (UNII: A9R10K3F2F) (LEVOMEFOLIC ACID - UNII:8S95DH25XC) LEVOMEFOLATE CALCIUM0.6 mg
Cyanocobalamin (UNII: P6YC3EG204) (Cyanocobalamin - UNII:P6YC3EG204) Cyanocobalamin0.013 mg
Calcium Carbonate (UNII: H0G9379FGK) (Calcium Cation - UNII:2M83C4R6ZB) Calcium Carbonate80 mg
Magnesium Oxide (UNII: 3A3U0GI71G) (Magnesium Cation - UNII:T6V3LHY838) Magnesium Oxide25 mg
FERROUS BISGLYCINATE (UNII: SFW1D987QV) (Ferrous Cation - UNII:GW89581OWR) Ferrous Cation20 mg
Potassium Iodide (UNII: 1C4QK22F9J) (Iodide Ion - UNII:09G4I6V86Q) Potassium Iodide0.15 mg
Inactive Ingredients
Ingredient NameStrength
MICROCRYSTALLINE CELLULOSE 102 (UNII: PNR0YF693Y)  
Maltodextrin (UNII: 7CVR7L4A2D)  
Croscarmellose Sodium (UNII: M28OL1HH48)  
Silicon Dioxide (UNII: ETJ7Z6XBU4)  
Stearic Acid (UNII: 4ELV7Z65AP)  
MAGNESIUM PALMITOSTEARATE (UNII: R4OXA9G5BV)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
Titanium Dioxide (UNII: 15FIX9V2JP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:71741-091-3030 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Dietary Supplement01/19/2021
Supplement Facts
Serving Size : Serving per Container :
Amount Per Serving% Daily Value
color
scoring1
shape
size (solid drugs)19 mm
Labeler - Redmont Pharmaceuticals, LLC (080843607)

Revised: 1/2021
Document Id: 081f5c84-4e49-451c-a533-b690248e7cee
Set id: 4933d66c-0372-4a6b-9385-b8e2d29ae795
Version: 1
Effective Time: 20210121
 
Redmont Pharmaceuticals, LLC